Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,718 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer.
Giridhar KV, Sanhueza C, Hillman DW, Alkhateeb H, Carlson R, Tan W, Costello BA, Quevedo F, Pagliaro L, Kohli M. Giridhar KV, et al. Among authors: tan w. Prostate Cancer Prostatic Dis. 2018 Sep;21(3):431-437. doi: 10.1038/s41391-018-0046-9. Epub 2018 Jun 1. Prostate Cancer Prostatic Dis. 2018. PMID: 29858590 Free PMC article.
Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients.
Kohli M, Li J, Du M, Hillman DW, Dehm SM, Tan W, Carlson R, Campion MB, Wang L, Wang L, Zhang H, Zhang P, Kilari D, Huang CC, Wang L. Kohli M, et al. Among authors: tan w. Prostate Cancer Prostatic Dis. 2018 Sep;21(3):411-418. doi: 10.1038/s41391-018-0043-z. Epub 2018 Jun 1. Prostate Cancer Prostatic Dis. 2018. PMID: 29858592 Free PMC article.
A Prospective Correlation of Tissue Histopathology With Nucleic Acid Yield in Metastatic Castration-Resistant Prostate Cancer Biopsy Specimens.
Jimenez RE, Atwell TD, Sicotte H, Eckloff B, Wang L, Barman P, Sinnwell JP, Eiken PW, McMenomy BP, Tan W, Wang L, Carlson RE, Kohli M. Jimenez RE, et al. Among authors: tan w. Mayo Clin Proc Innov Qual Outcomes. 2019 Feb 26;3(1):14-22. doi: 10.1016/j.mayocpiqo.2018.12.005. eCollection 2019 Mar. Mayo Clin Proc Innov Qual Outcomes. 2019. PMID: 30899904 Free PMC article.
The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients.
You B, Mercier F, Assenat E, Langlois-Jacques C, Glehen O, Soulé J, Payen L, Kepenekian V, Dupuy M, Belouin F, Morency E, Saywell V, Flacelière M, Elies P, Liaud P, Mazard T, Maucort-Boulch D, Tan W, Vire B, Villeneuve L, Ychou M, Kohli M, Joubert D, Prieur A. You B, et al. Among authors: tan w. EBioMedicine. 2020 Jan;51:102574. doi: 10.1016/j.ebiom.2019.11.035. Epub 2019 Dec 24. EBioMedicine. 2020. PMID: 31877416 Free PMC article.
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer.
Kohli M, Tan W, Zheng T, Wang A, Montesinos C, Wong C, Du P, Jia S, Yadav S, Horvath LG, Mahon KL, Kwan EM, Fettke H, Yu J, Azad AA. Kohli M, et al. Among authors: tan w. EBioMedicine. 2020 Apr;54:102728. doi: 10.1016/j.ebiom.2020.102728. EBioMedicine. 2020. PMID: 32268276 Free PMC article.
Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer.
Lin HM, Huynh K, Kohli M, Tan W, Azad AA, Yeung N, Mahon KL, Mak B, Sutherland PD, Shepherd A, Mellett N, Docanto M, Giles C, Centenera MM, Butler LM, Meikle PJ, Horvath LG. Lin HM, et al. Among authors: tan w. Prostate Cancer Prostatic Dis. 2021 Sep;24(3):860-870. doi: 10.1038/s41391-021-00338-z. Epub 2021 Mar 21. Prostate Cancer Prostatic Dis. 2021. PMID: 33746214 Free PMC article.
7,718 results